Department of Neurosurgery, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Department of Neurology, Cliniques Universitaires Saint-Luc, 10, avenue Hippocrate, 1200 Brussels, Belgium.
Neurochirurgie. 2020 Aug;66(4):252-257. doi: 10.1016/j.neuchi.2020.03.001. Epub 2020 Jun 1.
Deep brain stimulation (DBS) of the anterior thalamic nucleus (ATN) has been recognized to be an efficient treatment of refractory epilepsy (RE). However, ATN targeting is difficult and up to 8% of lead misplacement is reported. Our objective is to report our surgical procedure based on MRI targeting and our clinical results.
Our first five consecutive patients (4M, 1F, mean age: 42.8 years) treated by DBS of ATN between March and October 2016 were included. The mean duration of their epilepsy was 29 years. Four patients had already vagal nerve stimulation and 2 mammillary body stimulation. Stereotactic coordinates were calculated using distal segment of mammillothalamic tract as landmark. All procedures were performed under general anesthesia with intraoperative control of lead position using a robotic 3D fluoroscopy and image fusion with the preoperative MRI.
No complications or lead misplacement was observed. The mean 3D distance between the planned target and location of the lead was 1.8 mm. Each patient was followed up at least one year (15+3months). The stimulation parameters were: 140Hz, 90m/s and 5 Volts with one minute ON/five minutes OFF cycle. The mean reduction of seizure frequency reached -52.5% (+32.2) at 6-months but decreased to -24.5% (+65.7) at the last follow-up due to some adverse events not related to stimulation.
No complication, no lead misplacement and the improvement in our first patients, previously not help by multiple medications or surgeries, are encouraging.
已认识到丘脑前核(ATN)的深部脑刺激(DBS)是治疗难治性癫痫(RE)的有效方法。然而,ATN 的靶向定位具有一定难度,据报道有高达 8%的导联错位。我们的目的是报告基于 MRI 靶向的手术过程和临床结果。
我们纳入了 2016 年 3 月至 10 月间接受 ATN-DBS 治疗的前五位连续患者(4 男,1 女,平均年龄:42.8 岁)。他们癫痫的平均病程为 29 年。4 例患者已行迷走神经刺激,2 例行乳头体刺激。使用丘脑束远段作为标志计算立体定向坐标。所有手术均在全身麻醉下进行,术中使用机器人 3D 荧光透视术和术前 MRI 图像融合控制导联位置。
未观察到并发症或导联错位。计划靶区与导联位置之间的平均 3D 距离为 1.8mm。每位患者的随访时间至少 1 年(15+3 个月)。刺激参数为:140Hz、90m/s 和 5V,1 分钟开/5 分钟关循环。6 个月时癫痫发作频率平均减少了-52.5%(+32.2%),但由于一些与刺激无关的不良事件,最后一次随访时减少至-24.5%(+65.7%)。
在我们的前五位患者中,未观察到并发症、导联错位,并且在先前经过多种药物或手术治疗无效的患者中取得了改善,这是令人鼓舞的。